US 11046769
Multispecific binding constructs against checkpoint molecules and uses thereof
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 11046769 (Multispecific binding constructs against checkpoint molecules and uses thereof) held by Compass Therapeutics LLC expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Compass Therapeutics LLC
- Grant date
- Tue Jun 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61P, A61P35/00